Современные возможности лечения токсического зоба в регионе зобной эндемии

Скачать 11.62 Mb.
Размер11.62 Mb.
1   ...   7   8   9   10   11   12   13   14   15


Ardito G., Mantovani M., Vincenzoni C., Guidi M.L., Corsello S., Rabitti C., Fadda G., Di Giovanni V. Hyperthyroidism and carcinoma of the thyroid gland // Аnn. Ital. Chir. 1997. V. 68(1). P. 23-27.


Arslan H., Unal O., Algün E., Harman M., Sakarya M.E. Power Doppler sonography in the diagnosis of Graves' disease // Eur. J. Ultrasound. 2000 May. V. 11(2). P.117-22.


Baek H.J. Radiofrequency ablation therapy (RFAT) for benign thyroid nodules: the efficacy, safety, and factors affecting the results of treatment. Oral presentation // Abstracts of the 93rd Scientific Assembly and annual meeting of the Radiologic Society of North America. 2008.


Baek J.H., Moon W.J., Kim Y.S., Lee J.H., Lee D. Radiofrequency ablation for the treatment of autonomously function in thyroid nodules // World J. Surg. 2009. V.33 (9). P.1971-1977.


Baloch Z.W., Fleisher S., Livoski V.A. [et al.] Diagnosis of “follicular neoplasm” a grey zone in thyroid fine needle aspiration cytology // Diagn. Cytopathol. 2002. V. 26. P. 41-44.


Barakate M.S., Agarwal G., Reeve T.S. [et al.] Total thyroidectomy is now a preferred option for surgical management of Graves’ disease // ANZ. J. Surg. 2002. V.72 (5). P. 321-324.


Barclay L. Ethanol ablation safe, effective method for thyroid cystic nodules. Medscape Medical News. 2003.


Bartalena L. The dilemma of how to manage Graves hyperthyroidism in patients with associated orbitopathy // J. Clin. Endocrinol. Metab. 2011. V. 96. P. 592–599.


Bartos M., Kuzdak K., Kukulsky K., Narebsky J., Pomorsky L. Treatment of solitary toxic thyroid nodules with the use of percutaneous ethanol injections // Wiad. Lek. 2000. V. 53, N 1-2. P. 22-29.


Belfiore A., Garofalo M.R., Giuffrida D., Runello F., Filetti S., Fiumara A. [et al.] Increased aggressiveness of thyroid cancer in patients with Graves’ disease // J. Clin. Endocrinol. Metab. 1990. V. 70. P. 830–835.


Bielecka-Dabrowa A., Mikhailidis D.P., Rysz J., Banach M. The mechanisms of atrial fibrillation in hyperthyroidism // Thyroid Res. 2009. N 2. P. 4.


Biondi B., Kahaly G.J. Cardiovascular involvement in patients with different causes of hyperthyroidism // Nat. Rev. Endocrinol. 2010. N 8. P. 431–443.


Biondi B. Invited commentary: cardiovascular mortality in subclinical hyperthyroidism: an ongoing dilemma // Eur. J. Endocrinol. 2010. V. 162. P. 587–589.


Bitterman A., Uri O., Levanon A., Baron E., Lefel O., Cohen O. Thyroid carcinoma presenting as a hot nodule // Otolaryngol. Head, Neck Surg. 2006. V. 134 (5). P. 888-889.


Bojarska-Szmygin A., Ciechanek R., Jezierska B., Zaorska-Rajca. Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases // Pol. Merkur. Lekarski. 2002. V. 13(75). P. 196-199.


Brandt F, Green A, Hegedüs L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality // Eur. J. Endocrinol. 2011. V. 165. P. 491–497.


Brkjicic B., Sucic M., Borikov V. [et al.] Treatment of autonomous and toxic thyroid adenomas by percutaneous ultrasound-guided ethanol injections // Acta Radiol. 2001. V. 42(5). P. 321-324.


Brona A., Bohdanowicz-Pawlak A., Jdrzejuk D., Milewicz A. Fibrinogen and D-dimmers levels in patients with hyperthyroidism before and after radioiodine therapy // Endokrynologia Polska. 2011. V. 62(5). P. 409–415.


Bubnov A.N., Kuzmichev A.S., Fedotov Yu.N. Management of nodular thyroid goiter // Symposium on Endocrine Surgery. 2003. S-Petersburg. P. 23-34.


Bulow P.I., Laurberg P., Knudsen N. [et al.] Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark // J. Clin. Endocrinol. Metab. 2006. V. 91. P. 3830–3834.


Calò P.G., Pisano G., Medas F., Tatti A., Tuveri M., Nicolosi A. Risk factors in reoperative thyroid surgery for recurrent goiter: our experience // G. Chir. 2012. V. 33(10). P. 335-338.


Cappeli C., Pirola I., De Martino E. [et al.] The role of the imagining in Graves disease: A cost-effectiveness analysis // Eur. J. Radiol. 2008. V. 65(1). P. 99-103.


Cappelli C., Braga M., De Martino E., Castellano M., Gandossi E., Agosti B. [et al.] Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy // Surgery Today. 2006. V. 36. P. 25–30.


Cappola A.R., Fried L.P., Arnold A.M. [et al.] Thyroid status, cardiovascular risk, and mortality in older adults // JAMA. 2006. V. 295(9). P. 1033–1041.


Carlé A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB, Laurberg P. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study // Eur. J. Endocrinol. 2013. V. 169(5). P. 537-545.


Carneiro-Ramos M.S., Dinis G.P., Nadu A.P. [et al.] Blockage of angiotensin-II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking // Cardiol. 2010. V. 105. P. 325–335.


Carty S.E., Cooper D.S., Doherty G.M., Duh Q.Y., Kloos R.T., Mandel S.J., [et al.] Consensus statement on the terminology and classification of central neck dissection for thyroid cancer // Thyroid. 2009. V. 19. P. 1053–1058.


Cashman E.C., Bresnihan M., Timon C. Patients' quality of life post thyroidectomy // B-ENT. 2011. V. 7(4). P. 261-265.


Cesur M., Corapcioglu D., Bulut S., Gursoy A., Yilmaz A.E., Erdogan N., Kamel N. Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules // Thyroid. 2006. V. 16(6). P. 555-561.


Chen W.J., Yeh Y.H., Lin K.H., Chang G.J., Kuo C.T. Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism // Cardiol. 2011. V. 106. P. 163–174.


Chianelli M., Bizzarri G., Todino V., Misischi I., Bianchini A., Graziano F., Guglielmi R., Pacella C.M., Gharib H., Papini E. Lazer ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter // J. Clin. Endocrinol. Metab. 2014. V. 201, N 3. 59-67.


Chisholm E.J., Kulinskaya E., Tolley N.S. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone // Laryngoscope. 2009. V. 119. P. 1135–1139.


Chow T.L., Chu W., Lim B.H., Kwok S.P. Outcomes and complications of thyroid surgery: retrospective study // Hong Kong Med. J. 2001.V. 7(3). P. 261-265.


Coban E., Aydemir M., Yazicioglu G., Ozdogan M. Endothelial dysfunction in subjects with subclinical hyperthyroidism // Journal of Endocrinological Investigation. 2006. V. 29(3). P. 197–200.


Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J. [et al.] Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer // Thyroid. 2009. V. 19. P. 1167–214.


Dahl P., Danzi S., Klein I. Thyrotoxic cardiac disease // Cur. Heart Fail. Res. 2008. V. 5. P. 170–176.


Dănciulescu Miulescu R., Carşote M., Trifănescu R., Ferechide D., Poiană C. Antithyroid drugs induced agranulocytosis and multiple myeloma: case report and general considerations // J. Med. Life. 2013. V. 6(3). P. 327-31.


de Rooij A., Vandenbroucke J.P., Smit J.W., Stokkel M.P., Dekkers O.M. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis. // Eur. J. Endocrinol. 2009. V. 161(5). P. 771–777.


De Vos R.J., Bouvy N.D., Bonjer H.J. [et al.] // Fine needle aspiration cytology of thyroid nodules; how accurate is it? // Cytopathology. 2001. V. 12. P. 399-405.


Del Prete, Russo D., Caraglia M. [et al.] Percutaneous ethanol injection of autonomous thyroid nodules with volume larger than 40 ml; three years follow-up // Clin.Radiol. 2001. V. 56(11). P. 895-901.


Delange F., Benker G., Caron Ph. [et al.] Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency //European Journal of Endocrinology. 1997. V. 136. P. 180-187.


Dörr M., Wolff B., Robinson D.M. [et al.] The association of thyroid function with cardiac mass and left ventricular hypertrophy // The Journal of Clinical Endocrinology and Metabolism. 2005. V. 90(2). P. 673–677.


Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy // Surgery. 2001. V. 130(6). P. 971-7.


Enomoto K., Uchino S., Watanabe S., Enomoto Y., Noguchi S. Recurrent laryngeal nerve palsy during surgery for benign thyroid diseases: risk factors and outcome analysis // Surgery. 2014. V. 155(3). P. 522-528.


Erbil Y., Bozbora A., Yanik B.T., Ozbey N., Salmaslioğlu A., Ozarmağan S. Predictive factors for recurrent non-toxic goiter in an endemic region // J. Laryngol. Otol. 2007. V. 121(3). P. 231-236.


Erem C. Thyroid disorders and hyper coagulability. Seminars in Thrombosis and Hemostasis. 2011. V. 37(1). P. 17–26.


Ertek S., Cicero A.F. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology // Arch. Med. Sci. 2013 V. 9(5). P. 944-952.


Fay W.P., Garg N., Sunkar M. Vascular functions of the plasminogen activation system // Arteriosclerosis, Thrombosis, and Vascular Biology. 2007. V. 27(6). P. 1231-1237.


Ferrara A. Therapeutic indications for autonomous adenoma of the thyroid: 71 cases // Ann. Ital. Chir. 2000. V. 71(2). P. 177-180.


Fisher J.N. Management of thyrotoxicosis // South. Med. J. 2002. V. 95(5). P. 493-505.


Franco M., Chavez E., Perez-Mendez O. Pleiotropic effects of thyroid hormones: learning from hypothyroidism // J. Thyroid Res. 2011. V. 3 (2). P. 1030.


Galetta F., Franzoni F., Fallahi P. [et al.] Changes in autonomic regulation and ventricular repolarisation induced by subclinical hyperthyroidism // Biomed. Pharmacol. 2010. V. 64. P. 546–559.


Ghandour A., Reust C. Hyperthyroidism: a stepwise approach to treatment // J. Fam. Pract. 2011. V. 60. P. 388–395.


Gimondo P., Pizzi C., Gimondo S., Messina G. Ultrasonography, with Doppler color, and cytological correlations in Plummer's disease // Radiol. Med. 1998. V. 95(3). P.193-198.


Giuffrida D., Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules // Am. J. Med. 1995. V. 99. N 6. P. 642-650.


Goldstein R.E., Netterville J.L., Burkey B. [et al.] // Implications of follicular neoplasms atypia, and lesions suspicious for malignancy diagnosed by fine needle aspiration of thyroid nodules // Ann. Surg. 2002. V. 235(5). P. 656-662.


Gu L.Q., Zhao L., Zhu W. [et al.] Relationships between serum levels of thyroid hormones and serum concentrations of symmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT- pro BNP) in patients with Graves’ disease // Endocrine. 2011. V. 39. P. 266–271.


Guntekin U., Gunes Y., Tuncer M. [et al.] QTc dispersion in hyperthyroidism and its association with pulmonary hypertension // Pacing Clin. Electrophysiol. 2009. V. 32. P. 494–499.


Gurgul E., Sowinski J. Primary hyperthyroidism--diagnosis and treatment. Indications and contraindications for radioiodine therapy // Nucl. Med. Rev. Cent. East Eur. 2011. V. 14(1). P. 29-32.


Haddad F., Jiang W., Bodell P.W., Qin A.X., Baldwin K.M. Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications // Am. J. Physiol. Heart Circ. Physiol. 2010. V. 299. P. 1968–1980.


Harada Y., Akiyama H., Yoshimoto T., Urao Y., Ryuzaki M., Handa M. Thyroid storm with multiple organ failure, disseminated intravascular coagulation, and stroke with a normal serum FT3 level // Intern Med. 2012. V. 51(17). P. 2379-2383.


Hari Kumar K.V., Pasupuleti V., Jaraman M. [et al.] Role of Thyroid Doppler in differential diagnosis of thyrotoxicosis // Endocr. Pract. 2009. V. 15(1). P. 6-9


Harreld J.H, Kilani R.K., Lascola C.D., Bartz S.K. MR imaging of fetal goiter // AJNR Am. J. Neuroradiol. 2011. V. 32(8). P. 160.


Hassan I., Danila R., Maurer E., Osei-Agymang T., Zielke A. Severe Graves’ ophthalmopathy may be a risk factor for the development of post thyroidectomy hypocalcaemia // Exp. Clin. Endocrinol. Diabetes. 2008. V. 116. P. 614–618.


Heeringa J., Hoogendoorn E.H., van der Deure W.M. [et al.] High-normal thyroid function and risk of atrial fibrillation: the Rotterdam Study // Arch. Intern. Med. 2008. V. 168. P. 2219–2224.


Hegedus L., Dossing H., Bennebaek S.N. Laser thermal ablation of benign thyroid nodules – indications, technique,, effects and side effects // Materials of International Scientific conference “Minimally invasive technologies in endocrine surgery”. P. 117-120. St. Petersburg. 2008.


Hiromatsu Y. [et al.] Increased serum soluble F as in patients with Graves' disease // Thyroid. 1999. V. 9(4). P. 341-345.


Huang S.M., Chow N.H., Lee H.L. [et al.] The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves’ disease // Arch. Surg. 2003. V. 138(2). P. 146-151


Hundhahl S.A., Cady B., Cunningham M.P. Initial results from prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 // Cancer (Cytopathol). 2000. V. 89. P. 202-217.


Jacobson E.M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH-receptor and PTPN 22 gene quintet and its contribution to thyroid autoimmunity: back to the future // J. Autoimmun. 2007. V. 28(2-3). P. 85-98.


Janowitz P., Ackmann S. Langzeitergebnisse der ultraschallgestenerten Alkoholinstillation bei Patienten mit focalen Shilddrusenautonomic und Hyperthyreose // Med. Klin. 2001. V. 96(8). P. 451-456.


Jiskra J., Kubinyi J., Telička Z. Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option // Vnitr Lek. 2012. 58(2). P. 94-98.


Kaminski G., Michalkiewicz D., Makowski K. [et al.] Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism // Clinical Endocrinology. 2011. V. 74(4). P. 501–507.


Kasturi S., Ismail-Beigi F. Effect of thyroid hormone on the distribution and activity of Na, K ATPase in ventricular myocardium // Arch. Biochem. Biophys. 2008. V. 475. P. 121–127.


Kasuga Y., Kobayashi S., Fujimori M., Shingu K., Asanuma K., Hama Y., Ito K., Maruyama M., Amano J. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease // Eur. J. Surg. 1998. V. 164(3). P. 173-178.


Kittisupamongkol W. Hyperthyroidism or thyrotoxicosis? // Clev. Clin. J. Med. 2009. V. 76(3). P. 152


Klima G., Rothlauer W. Sonography of the thyroid gland //Acta Med. Austriaca 2000. V. 27, N.2. P. 42-44.


Kostka A. Risk factors of early recurrence after surgical treatment in Graves disease // Folia Med. Cracov. 2004. V. 45(1-2). P. 97-119.


Kozlowski D., Budrejko S., Lip G.Y. [et al.] Dronedarone: an overview // Ann. Med. 2012. V. 44. P. 60–72.


Krohn K., Führer D., Bayer Y., Eszlinger M., Brauer V., Neumann S., Paschke R. Molecular pathogenesis of euthyroid and toxic multinodular goiter // Endocr. Rev. 2005. V. 26(4). P. 504-524.


Lacka K., Fraczek M. Classification and etiology of hyperthyroidism // Pol. Merkur. Lekarski. 2014. V. 36(213). P. 206-211.


Lefevre J.H., Tresallet C., Leenhardt L., Jublanc C., Chigot J.P., Menegaux F. Re-operative surgery for thyroid disease // Langenbecks Arch. Surg. 2007. V. 392. P. 685–691.


Liebert M.A. Thyroid fine needle aspiration (FNA) and cytology // Thyroid. 2003. V. 13(1). P. 80-86.


Liel Y., Barchana M. Long term follow-up of patients with initially benign fine needle aspirations // Thyroid. 2001. V. 11. P. 775-778.


Limonard E.J., Bisschop P.H., Fliers E., Nieveen van Dijkum E.J. Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism // Scientific World Journal. 2012. V. 54. P. 87-96.


Lin H., Mitasikova M., Dlugosova K. [et al.] Thyroid hormones suppress epsilon PKC-signaling, down regulate connexin-43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rats // J. Physiol. Pharm. 2008.V. 59. P. 271–285.

Каталог: files -> science -> comming protection
comming protection -> Терапия кардиоселективными β-адреноблокаторами нарушений ритма сердца у больных хобл пожилого и старческого возраста 14. 01. 04. внутренние болезни
comming protection -> Выбор метода лечения гнойного холангита при механической желтухе у лиц пожилого и старческого возраста 14. 01. 17 хирургия
comming protection -> В сети Интернет 06. 05. 2015г. Абдулхаликов Абдулхалик Салимханович современные возможности лечения токсического зоба в регионе зобной эндемии 14. 01. 17. хирургия

Скачать 11.62 Mb.

Поделитесь с Вашими друзьями:
1   ...   7   8   9   10   11   12   13   14   15

База данных защищена авторским правом ©zodorov.ru 2020
обратиться к администрации

    Главная страница